Tops & Flops Stocks
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Sirona Biochem Corp. | -2.220% | 3.448% | 5.882% | -50.980% | -30.769% | -78.873% | -72.892% |
Inovio Pharma | -2.240% | - | - | - | - | - | - |
Cyclacel Pharmaceuticals Inc. | -2.260% | - | - | - | - | - | - |
SELLAS Life Sciences Group Inc | -2.270% | 2.591% | -10.811% | -27.027% | 21.846% | -82.027% | -99.677% |
Genomic Health | -2.270% | - | - | - | - | - | - |
Mayne Pharma Group Ltd. | -2.270% | 4.265% | 2.804% | 70.543% | 17.021% | 1718.182% | 960.241% |
ReproCell Inc | -2.290% | 5.645% | -6.429% | -59.063% | -28.415% | -79.403% | -67.429% |
China Medical System Holdings Ltd | -2.370% | 4.969% | -0.588% | -42.517% | -44.408% | -52.793% | 17.524% |
Essex Bio-Technology Ltd | -2.420% | - | - | - | - | - | - |
Puma Biotechnology Inc. | -2.450% | -1.144% | -13.114% | 54.630% | 15.032% | -44.115% | - |
Cellectis Nom. | -2.470% | 16.461% | 12.749% | 62.457% | -2.346% | -79.021% | - |
Minerva Neurosciences Inc. | -2.520% | 5.310% | 2.586% | -55.347% | -59.212% | -84.091% | - |
Syros Pharmaceuticals Inc. | -2.530% | 1.702% | 14.904% | 73.188% | -27.576% | -88.832% | - |
NanoCarrier Co Ltd | -2.530% | 2.597% | -26.168% | -44.366% | -33.051% | -62.381% | -76.689% |
Celldex Therapeutics | -2.540% | 9.091% | 4.918% | 26.316% | 6.077% | 74.071% | 623.164% |
Dynavax Technologies Corp | -2.580% | 1.925% | -2.251% | 9.403% | -15.558% | 34.711% | 87.058% |
Valneva SE | -2.590% | -2.412% | -11.661% | -41.003% | -30.426% | -73.002% | -2.555% |
Aclaris Therapeutics Inc | -2.650% | 1.526% | 2.725% | -85.216% | 19.053% | -94.276% | - |
Adverum Biotechnologies Inc. | -2.650% | - | - | - | - | - | - |
ConvaTec Group PLC | -2.650% | - | - | - | - | - | - |
Kura Oncology Inc | -2.670% | 5.516% | 3.815% | 91.287% | 50.938% | -8.868% | 40.960% |
ImmunityBio Inc. | -2.710% | -1.311% | 29.768% | 26.085% | 56.271% | -46.403% | - |
Cocrystal Pharma Inc. | -2.720% | 5.000% | 2.083% | -40.726% | -5.161% | -88.551% | - |
Pluristem Therapeutics Inc. | -2.750% | - | - | - | - | - | - |
Guerbet S.A. | -2.760% | 1.874% | 9.971% | 130.048% | 97.355% | 17.620% | -27.799% |